Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

838 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation.
Metafuni E, Cavattoni IM, Lamparelli T, Raiola AM, Ghiso A, Galaverna F, Gualandi F, Di Grazia C, Dominietto A, Varaldo R, Signori A, Chiusolo P, Sora' F, Giammarco S, Laurenti L, Sica S, Angelucci E, Bacigalupo A. Metafuni E, et al. Among authors: bacigalupo a. Blood Adv. 2022 Apr 12;6(7):2309-2318. doi: 10.1182/bloodadvances.2021005675. Blood Adv. 2022. PMID: 34920451 Free PMC article. Clinical Trial.
Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation.
Dominietto A, Lamparelli T, Raiola AM, Van Lint MT, Gualandi F, Berisso G, Bregante S, Di Grazia C, Soracco M, Pitto A, Frassoni F, Bacigalupo A. Dominietto A, et al. Among authors: bacigalupo a. Blood. 2002 Dec 1;100(12):3930-4. doi: 10.1182/blood-2002-01-0339. Epub 2002 Aug 1. Blood. 2002. PMID: 12393584 Free article.
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors.
Giebel S, Locatelli F, Lamparelli T, Velardi A, Davies S, Frumento G, Maccario R, Bonetti F, Wojnar J, Martinetti M, Frassoni F, Giorgiani G, Bacigalupo A, Holowiecki J. Giebel S, et al. Among authors: bacigalupo a. Blood. 2003 Aug 1;102(3):814-9. doi: 10.1182/blood-2003-01-0091. Epub 2003 Apr 10. Blood. 2003. PMID: 12689936 Free article. Clinical Trial.
Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma.
Corradini P, Cavo M, Lokhorst H, Martinelli G, Terragna C, Majolino I, Valagussa P, Boccadoro M, Samson D, Bacigalupo A, Russell N, Montefusco V, Voena C, Gahrton G; Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Corradini P, et al. Among authors: bacigalupo a. Blood. 2003 Sep 1;102(5):1927-9. doi: 10.1182/blood-2003-01-0189. Epub 2003 May 8. Blood. 2003. PMID: 12738666 Free article. Clinical Trial.
A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation.
Zino E, Frumento G, Marktel S, Sormani MP, Ficara F, Di Terlizzi S, Parodi AM, Sergeant R, Martinetti M, Bontadini A, Bonifazi F, Lisini D, Mazzi B, Rossini S, Servida P, Ciceri F, Bonini C, Lanino E, Bandini G, Locatelli F, Apperley J, Bacigalupo A, Ferrara GB, Bordignon C, Fleischhauer K. Zino E, et al. Among authors: bacigalupo a. Blood. 2004 Feb 15;103(4):1417-24. doi: 10.1182/blood-2003-04-1279. Epub 2003 Oct 23. Blood. 2004. PMID: 14576061 Free article.
838 results